Skip to content

Clinical trials

Completed Leukemia, Lymphocytic, Chronic, B-Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Status: Completed Country / region: China Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20133
20162
20172
20181
20191
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BeiGene3
Janssen Research & Development, LLC2
Pharmacyclics LLC.2
Chinese PLA General Hospital1
Eli Lilly and Company1
Jiangsu Simcere Pharmaceutical Co., Ltd.1
Shanghai YingLi Pharmaceutical Co. Ltd.1
Shenzhen Institute for Innovation and Translational Medicine1
Zhejiang DTRM Biopharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell13
Lymphoma, Large B-Cell, Diffuse4
Lymphoma, Mantle-Cell4
Lymphoma, B-Cell, Marginal Zone3
Recurrence3
Lymphoma, B-Cell2
Lymphoma, Follicular2
Lymphoma, Non-Hodgkin2
Hematologic Neoplasms1
Leukemia, Lymphoid1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.